Related references
Note: Only part of the references are listed.Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose
R. Scott Obach et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Protein damage by reactive electrophiles: Targets and consequences
Daniel C. Liebler
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Safety-related regulatory actions for biologicals approved in the United States and the European Union
Thijs J. Giezen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Dynamic Proteomics of Individual Cancer Cells in Response to a Drug
A. A. Cohen et al.
SCIENCE (2008)
The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates
Jeffrey A. Kramer et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products
Naomi L. Kruhlak et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data
J Seed et al.
CRITICAL REVIEWS IN TOXICOLOGY (2005)
Role of benoxaprofen and flunoxaprofen acyl glucuronides in covalent binding to rat plasma and liver proteins in vivo
JQ Dong et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002 - The importance of reporting suspected reactions
DK Wysowski et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Why drugs fail - A study on side effects in new chemical entities
D Schuster et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Human carcinogenic risk evaluation: An alternative approach to the two-year rodent bioassay
SM Cohen
TOXICOLOGICAL SCIENCES (2004)
Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development
DC Evans et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
Development of an in vitro screening model for the biosynthesis of acyl glucuronide metabolites and the assessment of their reactivity toward human serum albumin
S Bolze et al.
DRUG METABOLISM AND DISPOSITION (2002)
Alternative models for carcinogenicity testing
SM Cohen et al.
TOXICOLOGICAL SCIENCES (2001)
Concordance of the toxicity of pharmaceuticals in humans and in animals
H Olson et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2000)